0001225208-21-009385.txt : 20210614
0001225208-21-009385.hdr.sgml : 20210614
20210614212138
ACCESSION NUMBER: 0001225208-21-009385
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210614
FILED AS OF DATE: 20210614
DATE AS OF CHANGE: 20210614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOBO DONALD E JR
CENTRAL INDEX KEY: 0001196661
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15525
FILM NUMBER: 211016584
MAIL ADDRESS:
STREET 1: C/O EDWARDS LIFESCIENCES
STREET 2: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edwards Lifesciences Corp
CENTRAL INDEX KEY: 0001099800
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 364316614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
BUSINESS PHONE: 9492502500
MAIL ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP.
DATE OF NAME CHANGE: 20090225
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP
DATE OF NAME CHANGE: 20000203
FORMER COMPANY:
FORMER CONFORMED NAME: CVG CONTROLLED INC
DATE OF NAME CHANGE: 19991126
4
1
doc4.xml
X0306
4
2021-06-14
0001099800
Edwards Lifesciences Corp
EW
0001196661
BOBO DONALD E JR
ONE EDWARDS WAY
IRVINE
CA
92614
1
CVP,Strategy/Corp Development
Common Stock
2021-06-14
4
M
0
11050.0000
21.7600
A
67424.8505
D
Common Stock
2021-06-14
4
S
0
11050.0000
99.8372
D
56374.8505
D
Common Stock
38158.4268
I
401(k)
Common Stock
123820.0000
I
By Trust
Employee Stock Option (Right to Acquire)
21.7600
2021-06-14
4
M
0
11050.0000
0.0000
D
2016-05-14
2022-05-13
Common Stock
11050.0000
110500.0000
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021.
This transaction was executed in multiple trades at prices ranging from $99.6300 to $99.9100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.
Linda J. Park, Attorney-in-Fact
2021-06-14